Company
BioAtla, Inc. (BCAB)
Standardized SEC financial data for BioAtla, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001826892 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-164.7%
Free cash flow
-$48.2M
Current ratio
0.37×
EPS (diluted)
$-1.01
Ratios for fiscal year 2021, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $300K | — | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $238.6M | $245.0M | $215.5M | $111.5M | $49.0M | $7.1M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$36.3M | -$62.2M | -$90.4M | -$104.0M | -$71.9M | -$48.2M |
| Investing cash flow |
Get BCAB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BCAB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BCAB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"